Characteristics and treatment patterns among patients with HER2-amplified advanced/metastatic colorectal cancer (mCRC): A clinical-genomic database study

被引：2
|
作者：
Strickler, J. H. [1 ]
Hsu, L-I. [2 ]
DeBusk, K. [2 ]
Wright, P. [2 ]
Stecher, M. [3 ]
Siadak, M. [4 ]
Palanca-Wessels, M. C. [3 ]
Yu, J. [5 ]
Zhang, N. [6 ]
Espenschied, C. R. [7 ]
Lang, K. [6 ]
Bekaii-Saab, T. [8 ]
机构：
[1] Duke Canc Ctr, Div Med Oncol, Durham, NC USA
[2] Seagen Inc, Global Hlth Econ & Outcomes Res, Bothell, WA USA
[3] Seagen Inc, Clin Dev, Bothell, WA USA
[4] Seagen Inc, Med Affairs, Bothell, WA USA
[5] Guardant Hlth Inc, Clin Dev, Redwood City, CA USA
[6] Guardant Hlth Inc, Outcomes & Evidence, Redwood City, CA USA
[7] Guardant Hlth Inc, Med Affairs, Redwood City, CA USA
[8] Mayo Clin, Div Hematol Oncol, Phoenix, AZ USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.960
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
439P
引用
收藏
页码：S554 / S554
页数：1
相关论文
共 50 条
  • [1] Real-World Treatment Patterns in Patients With HER2-Amplified Metastatic Colorectal Cancer: A Clinical-Genomic Database Study
    Strickler, John H.
    Hsu, Ling-, I
    Wright, Phoebe
    Stecher, Michael
    Siadak, Muriel F.
    Palanca-Wessels, Maria Corinna
    Yu, Junhua
    Zhang, Nicole
    Espenschied, Carin R.
    Lang, Kathryn
    Bekaii-Saab, Tanios S.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (08): : 805 - +
  • [2] Survival outcome in HER2-amplified metastatic colorectal cancer (mCRC).
    Sawada, Kentaro
    Okamoto, Wataru
    Nakamura, Yoshiaki
    Yamanaka, Takeharu
    Yuki, Satoshi
    Yoshino, Takayuki
    Komatsu, Yoshito
    Sakamoto, Naoya
    Fujii, Satoshi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [3] Trastuzumab and lapatinib in HER2-amplified metastatic colorectal cancer patients (mCRC): The HERACLES trial.
    Siena, Salvatore
    Sartore-Bianchi, Andrea
    Lonardi, Sara
    Trusolino, Livio
    Martino, Cosimo
    Bencardino, Katia
    Leone, Francesco
    Zagonel, Vittorina
    Valtorta, Emanuele
    Torri, Valter
    Siravegna, Giulia
    Amatu, Alessio
    Bonazzina, Erica Francesca
    Rusconi, Francesca
    Ghezzi, Silvia
    Ciardiello, Fortunato
    Veronese, Silvio
    Comoglio, Paolo Maria
    Bardelli, Alberto
    Marsoni, Silvia
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] A systematic review of clinical trials of treatment regimens in HER2-amplified metastatic colorectal cancer
    Sur, Daniel
    Lungulescu, Cristina
    Dumitrescu, Elena Adriana
    Afrasanie, Vlad
    Spinu, Stefan
    Lungulescu, Cristian Virgil
    Schmoll, Hans-Joachim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (06) : 633 - 641
  • [5] Challenges in the Management of Patients With HER2-Amplified Colorectal Cancer
    Brown, Timothy J.
    Massa, Ryan C.
    JCO ONCOLOGY PRACTICE, 2022, 18 (08) : 555 - +
  • [6] Pertuzumab plus trastuzumab for HER2-amplified/overexpressed metastatic colorectal cancer (mCRC): Interim data from MyPathway
    Hurwitz, Herbert
    Raghav, Kanwal Pratap Singh
    Burris, Howard A.
    Kurzrock, Razelle
    Sweeney, Christopher
    Meric-Bernstam, Funda
    Vanderwalde, Ari M.
    Spigel, David R.
    Bose, Ron
    Fakih, Marwan
    Swanton, Charles
    Guo, Shuangli
    Bernaards, Coen
    Beattie, Mary Stanley
    Sommer, Nicolas
    Hainsworth, John D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [7] Post-treatment ctDNA analysis reveals patterns of HER2 therapy resistance in advanced HER2-amplified colorectal cancer
    Hoyek, C.
    Zheng-Lin, B.
    Abidoye, O.
    Walden, D.
    Eslinger, C.
    Sonbol, M. B.
    Wu, C.
    Ahn, D.
    Borad, M.
    Bekaii-Saab, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S33 - S33
  • [8] Clinical Response to T-DM1 in HER2-Amplified, KRAS-Mutated Metastatic Colorectal Cancer
    Sandhu, Jaideep
    Wang, Chongkai
    Fakih, Marwan
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (02): : 116 - 119
  • [9] Treatment patterns and site of metastasis in patients with metastatic colorectal cancer (mCRC)
    Iqbal, Sheikh Usman
    Thompson, Stephen F.
    Naoshy, Sarah
    Ng, Daniel B.
    Wooten, Michael
    Sherman, Steven A.
    Malangone, Elisabetta
    Stern, Lee
    Gorritz-Kindu, Magdaliz
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Efficacy and safety of HER2-targeted inhibitors for metastatic colorectal cancer with HER2-amplified: A meta-analysis
    Gao, Mengting
    Jiang, Ting
    Li, Pengcheng
    Zhang, Jie
    Xu, Ke
    Ren, Tao
    PHARMACOLOGICAL RESEARCH, 2022, 182
12345